Biotech · Private company
Jiangsu HengRui Medicine Co., Ltd.
Track this companyFree. Adds Jiangsu HengRui Medicine Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials94 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- ApatinibPhase 3 · Locally Advanced or Metastatic and Unresectable HCCClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 3 · Non-squamous NSCLCClinicalTrials.gov · fetched Nov 12, 2026
- Fuzuloparib , Abiraterone acetate and PrednisonePhase 3 · Metastatic Castration-Resistant Prostate Cancer (mCRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- Hetrombopag OlaminePhase 3 · Patients With Chemotherapy-Induced ThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
- PyrotinibPhase 3 · Non-squamous NSCLCClinicalTrials.gov · fetched Nov 12, 2026
- SHR-1210Phase 3 · Locally Advanced or Metastatic and Unresectable HCCClinicalTrials.gov · fetched Nov 12, 2026
- SorafenibPhase 3 · Locally Advanced or Metastatic and Unresectable HCCClinicalTrials.gov · fetched Nov 12, 2026
- INS068 injectionPhase 2 · Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Insulin DegludecPhase 2 · Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- SHR-1314Phase 2 · Moderate-to-severe Chronic Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- SHR-A1904Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Trastuzumab Rezetecan (SHR-A1811) injection; high dosePhase 2 · Advanced Colorectal Cancer Expressing HER2ClinicalTrials.gov · fetched Nov 12, 2026
- Trastuzumab Rezetecan (SHR-A1811) injection; low dosePhase 2 · Advanced Colorectal Cancer Expressing HER2ClinicalTrials.gov · fetched Nov 12, 2026
- SHR-A1811Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Global Trial of Trastuzumab Rezetecan (SHR-A1811) in Combination With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Colorectal Cancer Expressing HER2PHASE2 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07796763 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia (ExCIT)PHASE3 · RECRUITING · started Apr 16, 2026ClinicalTrials.gov NCT07286032 · fetched Nov 12, 2026
- A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORSPHASE1_PHASE2 · RECRUITING · started May 30, 2022ClinicalTrials.gov NCT05277168 · fetched Nov 12, 2026
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 18, 2021ClinicalTrials.gov NCT04691804 · fetched Nov 12, 2026
- A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral AntidiabeticsPHASE2 · COMPLETED · started Feb 4, 2021ClinicalTrials.gov NCT04663282 · fetched Nov 12, 2026
- Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based ChemotherapyPHASE3 · COMPLETED · started Sep 11, 2020ClinicalTrials.gov NCT04447118 · fetched Nov 12, 2026
- A Study of SHR-A1811 in Subjects With Advanced Malignant Solid TumorsPHASE1 · COMPLETED · started Sep 7, 2020ClinicalTrials.gov NCT04446260 · fetched Nov 12, 2026
- A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCCPHASE3 · COMPLETED · started Jun 10, 2019ClinicalTrials.gov NCT03764293 · fetched Nov 12, 2026
- Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque PsoriasisPHASE1_PHASE2 · COMPLETED · started Dec 15, 2017ClinicalTrials.gov NCT03463187 · fetched Nov 12, 2026